13G Filing: Armistice Capital and Depomed Inc (DEPO)

Item 6.

Ownership of More Than Five Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

N/A

		(ii)	Shared power to vote or to direct the vote
			Armistice Capital, LLC – 4,050,000 Armistice Capital Master Fund Ltd. – 4,050,000 Steven Boyd – 4,050,000
		(iii)	Sole power to dispose or to direct the disposition of
			Armistice Capital, LLC – 0 Armistice Capital Master Fund Ltd. – 0 Steven Boyd – 0
		(iv)	Shared power to dispose or to direct the disposition of
			Armistice Capital, LLC – 4,050,000 Armistice Capital Master Fund Ltd. – 4,050,000 Steven Boyd –4,050,000


Item 5.	Ownership of Five Percent or Less of a Class.

	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].

	N/A

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

	N/A

13G Filing: Armistice Capital and Depomed Inc (DEPO)

Published on August 18, 2017 at 4:39 pm by Insider Monkey Staff in Hedge Funds

Page 7 of 10 – SEC Filing

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff